Wyeth Sets Webcast and Conference Call For 2009 Second Quarter Earnings
June 10 2009 - 9:40AM
PR Newswire (US)
MADISON, N.J., June 10 /PRNewswire-FirstCall/ -- On Thursday, July
23, 2009, Wyeth (NYSE:WYE) will announce financial results for the
2009 second quarter. The Company will hold a conference call with
research analysts at 8:00 a.m. Eastern Time on July 23, 2009.
Interested investors and others may listen to the call live or on a
delayed basis through our Internet webcast, which may be accessed
by visiting our website at http://www.wyeth.com/ and clicking on
the "Investor Relations" icon. Wyeth is one of the world's largest
research-driven pharmaceutical and health care products companies.
It is a leader in the discovery, development, manufacturing, and
marketing of pharmaceuticals, vaccines, biotechnology products, and
non-prescription medicines that improve the quality of life for
people worldwide. The Company's major divisions include Wyeth
Pharmaceuticals, Wyeth Consumer Healthcare and Fort Dodge Animal
Health. The statements in this press release that are not
historical facts are forward-looking statements that are subject to
risks and uncertainties that could cause actual results to differ
materially from those expressed or implied by such statements.
These risks and uncertainties include, among others, risks related
to our proposed merger with Pfizer, including satisfaction of the
conditions of the proposed merger on the proposed timeframe or at
all, contractual restrictions on the conduct of our business
included in the merger agreement, and the potential for loss of key
personnel, disruption in key business activities or any impact on
our relationships with third parties as a result of the
announcement of the proposed merger; the inherent uncertainty of
the timing and success of, and expense associated with, research,
development, regulatory approval and commercialization of our
products and pipeline products; government cost-containment
initiatives; restrictions on third-party payments for our products;
substantial competition in our industry, including from branded and
generic products; emerging data on our products and pipeline
products; the importance of strong performance from our principal
products and our anticipated new product introductions; the highly
regulated nature of our business; product liability, intellectual
property and other litigation risks and environmental liabilities;
the outcome of government investigations; uncertainty regarding our
intellectual property rights and those of others; difficulties
associated with, and regulatory compliance with respect to,
manufacturing of our products; risks associated with our strategic
relationships; global economic conditions; interest and currency
exchange rate fluctuations and volatility in the credit and
financial markets; changes in generally accepted accounting
principles; trade buying patterns; the impact of legislation and
regulatory compliance; risks and uncertainties associated with
global operations and sales; and other risks and uncertainties,
including those detailed from time to time in our periodic reports
filed with the Securities and Exchange Commission, including our
current reports on Form 8-K, quarterly reports on Form 10-Q and
annual report on Form 10-K, particularly the discussion under the
caption "Item 1A, Risk Factors" in our Annual Report on Form 10-K
for the year ended December 31, 2008, which was filed with the
Securities and Exchange Commission on February 27, 2009. The
forward-looking statements in this press release are qualified by
these risk factors. We assume no obligation to publicly update any
forward-looking statements, whether as a result of new information,
future developments or otherwise. DATASOURCE: Wyeth CONTACT: Media,
Douglas Petkus, +1-973-660-5218, or Investors, Justin Victoria,
+1-973-660-5340, both for Wyeth Web Site: http://www.wyeth.com/
Copyright
Wyeth (NYSE:WYE)
Historical Stock Chart
From May 2024 to Jun 2024
Wyeth (NYSE:WYE)
Historical Stock Chart
From Jun 2023 to Jun 2024